Correction for Bielekova et al., Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon {beta}, PNAS 2004 101:8705-8708

MEDICAL SCIENCES. For the article “Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β,” by Bibiana Bielekova, Nancy Richert, Thomas Howard, Gregg Blevins, Silva Markovic-Plese, Jennifer McCartin, Jens Würfel, Joan Ohayon, Thomas A. Waldmann, Henry F. McFarland, and Roland Martin, which appeared in issue 23, …

[Full Text of this Article]
« Previous | Next Article »Table of Contents

This Article

  1. Published online before print November 29, 2004, doi: 10.1073/pnas.0404694101 PNAS December 14, 2004 vol. 101 no. 50 17565
  1. Correction to Bielekova et al. 101 (23): 8705
  1. » Extract
  2. Full Text
  3. Full Text (PDF)

Classifications

About Our New Site Design >>
Link: Advanced Search

This Week's Issue

  1. November 11, 2008, 105 (45)
  1. Current Issue
  1. Alert me to new issues of PNAS

Most